Synonym
NIH 10236; NIH-10236; NIH10236
IUPAC/Chemical Name
2-Butenoic acid, 4-(((5alpha,7alpha)-17-(cyclopropylmethyl)-4,5-epoxy-3-hydroxy-6-methoxy-6,14-ethenomorphinan-7-yl)amino)-4-oxo-, methyl ester, (E)-
InChi Key
HMSNRTYBCBHRBA-VJXYYDRWSA-N
InChi Code
InChI=1S/C28H32N2O6/c1-34-22(33)8-7-21(32)29-19-14-26-9-10-28(19,35-2)25-27(26)11-12-30(15-16-3-4-16)20(26)13-17-5-6-18(31)24(36-25)23(17)27/h5-10,16,19-20,25,31H,3-4,11-15H2,1-2H3,(H,29,32)/b8-7+/t19-,20-,25-,26+,27+,28?/m1/s1
SMILES Code
O=C(OC)/C=C/C(N[C@H]1C2(OC)[C@@]3([H])[C@]45C6=C(O3)C(O)=CC=C6C[C@@H](N(CC7CC7)CC5)[C@]4(C=C2)C1)=O
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
492.57
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Richards ML, Sadeé W. In vivo binding of putative delta-selective opioid antagonists to central opiate receptors. Eur J Pharmacol. 1986 Jul 31;126(3):313-6. doi: 10.1016/0014-2999(86)90064-6. PMID: 3019718.
2: James SP. Enhancing endoscopic research. Gastrointest Endosc. 2004 Feb;59(2):328. doi: 10.1016/s0016-5107(03)02690-7. PMID: 14989231.
3: Jacobson AE, Bajwa BS, Streaty RA, Klee WA, Rice KC. Probes for narcotic receptor mediated phenomena. 5. Narcotic antagonist irreversible ligands based on endoethenotetrahydrooripavine. Life Sci. 1983;33 Suppl 1:159-62. doi: 10.1016/0024-3205(83)90468-x. PMID: 6319854.
4: Mirkes P, McClure ME, Heindel JJ, Sander M. Developmental toxicology in the 21st century: multidisciplinary approaches using model organisms and genomics. Birth Defects Res A Clin Mol Teratol. 2003 Jan;67(1):21-34. doi: 10.1002/bdra.10024. PMID: 12749381.
5: Rothman RB, Long JB, Holaday JW, Bykov V, de Costa BR, Kim CH, Jacobson AE, Rice KC. A study of the interaction of the alkylating agent, NIH10236, with opioid receptors in vitro and in vivo. Neuropharmacology. 1989 Dec;28(12):1349-56. doi: 10.1016/0028-3908(89)90009-9. PMID: 2559348.
6: Department of Health and Human Services. Recombinant DNA Advisory Committee. National Institutes of Health. Minutes of Meeting. June 14, 1999. Hum Gene Ther. 2000 Jun 10;11(9):1369-82. doi: 10.1089/10430340050032456. PMID: 11032449.
